跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-IMIPRAMINE TABLET 25MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-IMIPRAMINE TABLET 25MG
Approved
THERAPEUTIC
APO-IMIPRAMINE TABLET 25MG
APOTEX INC (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Apr 20, 1990
Approval ID
543a922f8fbe9e51
Company
APOTEX INC (CANADA)
Type
Therapeutic
Approval Details
Approval Id
543a922f8fbe9e51
Drug Name
APO-IMIPRAMINE TABLET 25MG
Product Name
APO-IMIPRAMINE TABLET 25MG
Approval Number
SIN04154P
Approval Date
1990-04-20
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
N06AA02
Atc Item Name
imipramine
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
IMIPRAMINE HCl
25 mg
IMIPRAMINE HCL
25 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 20, 1990
Approval ID
543a922f8fbe9e51
Type
Therapeutic
Back to HSA Approvals